Cassidy Drug Pricing Plan Stalled As Senate GOP Rejects MFN Approach

By Maaisha Osman / July 31, 2025 at 6:49 PM

Senate health committee Chair Bill Cassidy’s (R-LA) proposal to penalize drugmakers that charge lower prices overseas is currently on hold, two people familiar with the matter told Inside Health Policy, as many Senate Republicans remain opposed to “most favored nation” (MFN) pricing policies -- even as President Donald Trump on Thursday (July 31) doubled down on his executive order to implement the policy.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.